Home > Result Summaries: Compounds > ipratropium bromide Result Summaries: ipratropium bromide GSKStudy ID Phase Title Summary (Download) 100539 Phase 1 A double-blind, randomised, placebo-controlled, double-dummy, four-way cross-over study to evaluate the bronchodilatory effect of single doses of tiotropium bromide [18 mg administered via dry-powder inhaler (DPI)] and salmeterol (50 or 100 mg via DPI) in patients with… (0 citation(s))
